FOXP3 and non-small cell lung carcinoma: Overall, understanding the prognostic significance of FOXP3 in NSCLC tumors and its involvement in therapy resistance may help to develop more effective targeted therapeutic strategies to improve clinical outcomes in patients with lung cancer.